chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: has no appetite; fever up to 100.1F; headache; chills; nausea; was tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (has no appetite), PYREXIA (fever up to 100.1F), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure since an unknown date. Concomitant products included VITAMINS NOS for an unknown indication.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced DECREASED APPETITE (has no appetite), PYREXIA (fever up to 100.1F), HEADACHE (headache), CHILLS (chills), NAUSEA (nausea) and FATIGUE (was tired). The patient was treated with PARACETAMOL (TYLENOL) on 01-Feb-2021 at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (has no appetite), PYREXIA (fever up to 100.1F), HEADACHE (headache), CHILLS (chills), NAUSEA (nausea) and FATIGUE (was tired) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, Body temperature: 100.1 (Inconclusive) fever up to 100.1F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Statins and blood pressure medication are the other concomitant medications reported by reporter.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: has no appetite; fever up to 100.1F; headache; chills; nausea; was tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (has no appetite), PYREXIA (fever up to 100.1F), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure since an unknown date. Concomitant products included VITAMINS NOS for an unknown indication.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced DECREASED APPETITE (has no appetite), PYREXIA (fever up to 100.1F), HEADACHE (headache), CHILLS (chills), NAUSEA (nausea) and FATIGUE (was tired). The patient was treated with PARACETAMOL (TYLENOL) on 01-Feb-2021 at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (has no appetite), PYREXIA (fever up to 100.1F), HEADACHE (headache), CHILLS (chills), NAUSEA (nausea) and FATIGUE (was tired) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, Body temperature: 100.1 (Inconclusive) fever up to 100.1F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Statins and blood pressure medication are the other concomitant medications reported by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: We inadvertently administered doses from a vial that was in our refrigerator for more than 30 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of   in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-037831 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No specific follow-up information recorded.; Sender's Comments: This report refers to a case of Product storage error for mRNA-1273, lot # unknown  with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Heart rate increased, Swelling, Vaccination site pain, Vaccination site pruritus
Clinical narrative: fast heartrate; weakness; swelling; felt her arm itchy; rash at the vaccination site; a sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heartrate), ASTHENIA (weakness), SWELLING (swelling), VACCINATION SITE PRURITUS (felt her arm itchy) and VACCINATION SITE RASH (rash at the vaccination site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included DENOSUMAB (PROLIA), AMLODIPINE, LOSARTAN, METOPROLOL, PRAVASTATIN, RALOXIFENE, LEVOTHYROXINE and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (a sore arm at the injection site). On 22-Jan-2021, the patient experienced HEART RATE INCREASED (fast heartrate), ASTHENIA (weakness), SWELLING (swelling), VACCINATION SITE PRURITUS (felt her arm itchy) and VACCINATION SITE RASH (rash at the vaccination site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (fast heartrate), ASTHENIA (weakness), SWELLING (swelling), VACCINATION SITE PRURITUS (felt her arm itchy), VACCINATION SITE RASH (rash at the vaccination site) and VACCINATION SITE PAIN (a sore arm at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: fast heartrate; weakness; swelling; felt her arm itchy; rash at the vaccination site; a sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heartrate), ASTHENIA (weakness), SWELLING (swelling), VACCINATION SITE PRURITUS (felt her arm itchy) and VACCINATION SITE RASH (rash at the vaccination site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included DENOSUMAB (PROLIA), AMLODIPINE, LOSARTAN, METOPROLOL, PRAVASTATIN, RALOXIFENE, LEVOTHYROXINE and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (a sore arm at the injection site). On 22-Jan-2021, the patient experienced HEART RATE INCREASED (fast heartrate), ASTHENIA (weakness), SWELLING (swelling), VACCINATION SITE PRURITUS (felt her arm itchy) and VACCINATION SITE RASH (rash at the vaccination site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (fast heartrate), ASTHENIA (weakness), SWELLING (swelling), VACCINATION SITE PRURITUS (felt her arm itchy), VACCINATION SITE RASH (rash at the vaccination site) and VACCINATION SITE PAIN (a sore arm at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Low grade -fever; Fatigue; painful touch at the site of injection/ warm touch at the injection site; itchy rump at the injection site; swollen at the injection site; red at the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (Low grade -fever), FATIGUE (Fatigue), VACCINATION SITE PAIN (painful touch at the site of injection/ warm touch at the injection site), VACCINATION SITE PRURITUS (itchy rump at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fever since 14-Jan-2021, Fatigue since 14-Jan-2021, Painful arm since 14-Jan-2021, Itchy since 24-Jan-2021, Swollen arm since 24-Jan-2021 and Erythema on 24-Jan-2021.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (Low grade -fever), FATIGUE (Fatigue), VACCINATION SITE PAIN (painful touch at the site of injection/ warm touch at the injection site), VACCINATION SITE PRURITUS (itchy rump at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE ERYTHEMA (red at the injection site). At the time of the report, PYREXIA (Low grade -fever) had not resolved and FATIGUE (Fatigue), VACCINATION SITE PAIN (painful touch at the site of injection/ warm touch at the injection site), VACCINATION SITE PRURITUS (itchy rump at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE ERYTHEMA (red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Low grade -fever; Fatigue; painful touch at the site of injection/ warm touch at the injection site; itchy rump at the injection site; swollen at the injection site; red at the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (Low grade -fever), FATIGUE (Fatigue), VACCINATION SITE PAIN (painful touch at the site of injection/ warm touch at the injection site), VACCINATION SITE PRURITUS (itchy rump at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fever since 14-Jan-2021, Fatigue since 14-Jan-2021, Painful arm since 14-Jan-2021, Itchy since 24-Jan-2021, Swollen arm since 24-Jan-2021 and Erythema on 24-Jan-2021.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (Low grade -fever), FATIGUE (Fatigue), VACCINATION SITE PAIN (painful touch at the site of injection/ warm touch at the injection site), VACCINATION SITE PRURITUS (itchy rump at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE ERYTHEMA (red at the injection site). At the time of the report, PYREXIA (Low grade -fever) had not resolved and FATIGUE (Fatigue), VACCINATION SITE PAIN (painful touch at the site of injection/ warm touch at the injection site), VACCINATION SITE PRURITUS (itchy rump at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE ERYTHEMA (red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: swollen hands; red hands; itching on the inside of the hands; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen hands), ERYTHEMA (red hands) and PRURITUS (itching on the inside of the hands) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen hands), ERYTHEMA (red hands) and PRURITUS (itching on the inside of the hands). At the time of the report, PERIPHERAL SWELLING (swollen hands), ERYTHEMA (red hands) and PRURITUS (itching on the inside of the hands) had resolved.            Concomitant medications included Vaseline Intensive Care Lotion.  The patient reported that the symptoms started on the left hand and then spread to the right hand.  No treatment was reported for the events.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: TCR form received on 12-JUL-2021 contains event outcome was updated.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  No treatment details were provided; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Pain, Pyrexia
Clinical narrative: not hungry; a little achy; fever of 100; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (not hungry), PAIN (a little achy) and PYREXIA (fever of 100) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 030O20A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, FLUOXETINE, OMEPRAZOLE, SPIRONOLACTONE and LEVOTHYROXINE for an unknown indication.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced DECREASED APPETITE (not hungry), PAIN (a little achy) and PYREXIA (fever of 100). The patient was treated with PARACETAMOL (TYLENOL) on 02-Feb-2021 at a dose of 2 in the evening. At the time of the report, DECREASED APPETITE (not hungry), PAIN (a little achy) and PYREXIA (fever of 100) outcome was unknown.            Treatment medication included Tylenol.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: pretty significant joint pain; headache; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (pretty significant joint pain) and HEADACHE (headache) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced ARTHRALGIA (pretty significant joint pain) and HEADACHE (headache). On 02-Feb-2021, ARTHRALGIA (pretty significant joint pain) had resolved. At the time of the report, HEADACHE (headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event,s a causal relationship cannot be excluded.  Nevertheless, for the event headache the concomitant drug adderall could be a confounder.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Sensory disturbance
Clinical narrative: Sensation in tongue/ Sensation on lip; Generalized itching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of SENSORY DISTURBANCE (Sensation in tongue/ Sensation on lip) and PRURITUS (Generalized itching) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SENSORY DISTURBANCE (Sensation in tongue/ Sensation on lip) and PRURITUS (Generalized itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at a dose of 1 UNK. At the time of the report, SENSORY DISTURBANCE (Sensation in tongue/ Sensation on lip) and PRURITUS (Generalized itching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked.   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Follow-Up information received on 05-Apr-2021 contains No Significant information.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Glucose tolerance test, Maternal exposure during pregnancy, Pregnancy test, Prenatal screening test, Ultrasound scan normal
Clinical narrative: got both doses of vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (got both doses of vaccine while pregnant) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (0-1 drink per week). Concomitant products included PRENATAL + DHA for Pregnancy.   On 06-Jan-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021 at 10:10 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 02-Jun-2020 and the estimated date of delivery was 09-Mar-2021. On 06-Jan-2021 at 10:10 AM, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (got both doses of vaccine while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 03-Feb-2021 at 10:10 AM, MATERNAL EXPOSURE DURING PREGNANCY (got both doses of vaccine while pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jul-2020, Pregnancy test: positive (Positive) positive. In August 2020, Prenatal screening test: negative (Negative) First trimester-Negative. In October 2020, Ultrasound scan normal: normal (normal) Normal. On 15-Dec-2020, Glucose tolerance test: 78 (Inconclusive) 78. On 21-Jan-2021, Ultrasound scan normal: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-173 in response to the event was not applicable.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-Feb-2021: Internal review conducted on 21-JUL-2021, resulted in updates to the pregnancy details, patient and vaccine information, event coding to "maternal exposure during pregnancy", event onset date and iNarrative supplement.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus
Clinical narrative: Delayed Itching Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Delayed Itching Injection Site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 630L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced INJECTION SITE PRURITUS (Delayed Itching Injection Site). At the time of the report, INJECTION SITE PRURITUS (Delayed Itching Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.; Sender's Comments: This case concerns a 69-year-old female who experienced a NS unexpected event of Injection site pruritus.  Event onset occurred 8 days after the first dose of mRNA-1273. Treatment not reported. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID19; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID19) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medicines were not provided,  Several medications to treat COVID19 symptoms prescribed by patients doctor  Action taken with mRNA-1273 in response to the event was unknown   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: unusual and unwanted side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (unusual and unwanted side effects) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (unusual and unwanted side effects). At the time of the report, ADVERSE EVENT (unusual and unwanted side effects) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Myalgia, Pain in extremity
Clinical narrative: Fever; Bodyache; Headache; Weakness; Arm was sore; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Bodyache), HEADACHE (Headache), ASTHENIA (Weakness) and PAIN IN EXTREMITY (Arm was sore) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced PYREXIA (Fever), MYALGIA (Bodyache), HEADACHE (Headache), ASTHENIA (Weakness), PAIN IN EXTREMITY (Arm was sore) and CHILLS (Chills). At the time of the report, PYREXIA (Fever), MYALGIA (Bodyache), HEADACHE (Headache), ASTHENIA (Weakness), PAIN IN EXTREMITY (Arm was sore) and CHILLS (Chills) outcome was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Bodyache; Headache; Weakness; Arm was sore; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Bodyache), HEADACHE (Headache), ASTHENIA (Weakness) and PAIN IN EXTREMITY (Arm was sore) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced PYREXIA (Fever), MYALGIA (Bodyache), HEADACHE (Headache), ASTHENIA (Weakness), PAIN IN EXTREMITY (Arm was sore) and CHILLS (Chills). At the time of the report, PYREXIA (Fever), MYALGIA (Bodyache), HEADACHE (Headache), ASTHENIA (Weakness), PAIN IN EXTREMITY (Arm was sore) and CHILLS (Chills) outcome was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Appetite disorder, Asthenia, Feeling hot
Clinical narrative: Fever; Pain in the stomach; Burning head; felt very hot; discomfort in stomach; not feeling hungry; do not have energy/Very weak; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), HEADACHE (Burning head), FEELING HOT (felt very hot) and ABDOMINAL DISCOMFORT (discomfort in stomach) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), HEADACHE (Burning head), FEELING HOT (felt very hot), ABDOMINAL DISCOMFORT (discomfort in stomach), APPETITE DISORDER (not feeling hungry) and ASTHENIA (do not have energy/Very weak). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Fever, at an unspecified dose and frequency. On 25-Jan-2021, PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), HEADACHE (Burning head), FEELING HOT (felt very hot), ABDOMINAL DISCOMFORT (discomfort in stomach) and APPETITE DISORDER (not feeling hungry) had resolved. At the time of the report, ASTHENIA (do not have energy/Very weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever; Pain in the stomach; Burning head; felt very hot; discomfort in stomach; not feeling hungry; do not have energy/Very weak; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), HEADACHE (Burning head), FEELING HOT (felt very hot) and ABDOMINAL DISCOMFORT (discomfort in stomach) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), HEADACHE (Burning head), FEELING HOT (felt very hot), ABDOMINAL DISCOMFORT (discomfort in stomach), APPETITE DISORDER (not feeling hungry) and ASTHENIA (do not have energy/Very weak). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Fever, at an unspecified dose and frequency. On 25-Jan-2021, PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), HEADACHE (Burning head), FEELING HOT (felt very hot), ABDOMINAL DISCOMFORT (discomfort in stomach) and APPETITE DISORDER (not feeling hungry) had resolved. At the time of the report, ASTHENIA (do not have energy/Very weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site rash
Clinical narrative: Swollen arm; Little bit of a rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE RASH (Little bit of a rash around the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE RASH (Little bit of a rash around the injection site). At the time of the report, PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE RASH (Little bit of a rash around the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Adverse reaction). At the time of the report, ADVERSE REACTION (Adverse reaction) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Redness at the injection site; Swelling at the injection site; A spontaneous report  was received from a Consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced redness at the injection site and swelling at the injection site.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: UNKNOWN) for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events Redness at the injection site (injection site erythema) and Swelling at the injection site (injection site swelling) that lasted 3.5 weeks.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Fatigue, Feeling abnormal
Clinical narrative: Got very week; Not feeling great; Pain on joints; Fever; Chills; Couldn't get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Got very week), FEELING ABNORMAL (Not feeling great), ARTHRALGIA (Pain on joints), PYREXIA (Fever) and CHILLS (Chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced ASTHENIA (Got very week), FEELING ABNORMAL (Not feeling great), ARTHRALGIA (Pain on joints), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Couldn't get out of bed). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 31-Jan-2021, FATIGUE (Couldn't get out of bed) had resolved. At the time of the report, ASTHENIA (Got very week), FEELING ABNORMAL (Not feeling great), ARTHRALGIA (Pain on joints), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No concomitant medication reported   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Contact information updated, second dose details updated and no AE reported for 2nd dose
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Got very week; Not feeling great; Pain on joints; Fever; Chills; Couldn't get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Got very week), FEELING ABNORMAL (Not feeling great), ARTHRALGIA (Pain on joints), PYREXIA (Fever) and CHILLS (Chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced ASTHENIA (Got very week), FEELING ABNORMAL (Not feeling great), ARTHRALGIA (Pain on joints), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Couldn't get out of bed). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 31-Jan-2021, FATIGUE (Couldn't get out of bed) had resolved. At the time of the report, ASTHENIA (Got very week), FEELING ABNORMAL (Not feeling great), ARTHRALGIA (Pain on joints), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No concomitant medication reported   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Contact information updated, second dose details updated and no AE reported for 2nd dose
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site inflammation, Vaccination site swelling, Vaccination site warmth
Clinical narrative: site is about 3" round; It's also hot and warm to touch; hardness; site went red; swollen arm, a couple inches in diameter; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE INFLAMMATION (site is about 3" round), VACCINATION SITE WARMTH (It's also hot and warm to touch), VACCINATION SITE INDURATION (hardness), VACCINATION SITE SWELLING (swollen arm, a couple inches in diameter) and VACCINATION SITE ERYTHEMA (site went red) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swollen arm, a couple inches in diameter). On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (site is about 3" round), VACCINATION SITE WARMTH (It's also hot and warm to touch), VACCINATION SITE INDURATION (hardness) and VACCINATION SITE ERYTHEMA (site went red). At the time of the report, VACCINATION SITE INFLAMMATION (site is about 3" round), VACCINATION SITE WARMTH (It's also hot and warm to touch), VACCINATION SITE INDURATION (hardness), VACCINATION SITE SWELLING (swollen arm, a couple inches in diameter) and VACCINATION SITE ERYTHEMA (site went red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Neuralgia, Paraesthesia, Vaccination site pain, Vaccination site swelling
Clinical narrative: Numbness on fingers; What she describes as "nerve symptom; Tingle on fingers; She is feeling "complete pain" on the same arm of the injection; Swelling of her arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (Numbness on fingers), NEURALGIA (What she describes as "nerve symptom), PARAESTHESIA (Tingle on fingers), VACCINATION SITE PAIN (She is feeling "complete pain" on the same arm of the injection) and VACCINATION SITE SWELLING (Swelling of her arm) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030o20a and 011g20a) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness on fingers), NEURALGIA (What she describes as "nerve symptom), PARAESTHESIA (Tingle on fingers), VACCINATION SITE PAIN (She is feeling "complete pain" on the same arm of the injection) and VACCINATION SITE SWELLING (Swelling of her arm). At the time of the report, HYPOAESTHESIA (Numbness on fingers), NEURALGIA (What she describes as "nerve symptom), PARAESTHESIA (Tingle on fingers), VACCINATION SITE PAIN (She is feeling "complete pain" on the same arm of the injection) and VACCINATION SITE SWELLING (Swelling of her arm) had not resolved.            Treatment details included she had not taken any medication yet, but she is going to take Ibuprofen.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: small blotchy rash below injection site presenting a week later; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (small blotchy rash below injection site presenting a week later) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (small blotchy rash below injection site presenting a week later). At the time of the report, VACCINATION SITE RASH (small blotchy rash below injection site presenting a week later) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported No treatment was reported.   Reporter did not allow further contact
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fatigue; Headache; Upper Body Pain; Elevated Temperature (98.8F - High for Her; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (Positive COVID-19 test), ASTHMA (Asthma), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Upper Body Pain) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Upper Body Pain) and PYREXIA (Elevated Temperature (98.8F - High for Her). On 22-Jan-2021, the patient experienced COVID-19 (Positive COVID-19 test). On an unknown date, the patient experienced ASTHMA (Asthma). At the time of the report, COVID-19 (Positive COVID-19 test), ASTHMA (Asthma), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Upper Body Pain) and PYREXIA (Elevated Temperature (98.8F - High for Her) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The consumer is reports being diagnosed with Asthma and takes "Teva" (Albuterol) to alleviate her flare ups.  Concomitant and treatment information not provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash
Clinical narrative: Flat Rash; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE RASH (Flat Rash) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J202A and 025J202A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 29-Jan-2021, the patient experienced VACCINATION SITE RASH (Flat Rash). On 14-Jan-2021, PAIN IN EXTREMITY (Pain in arm) had resolved. On 02-Feb-2021, VACCINATION SITE RASH (Flat Rash) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Products known to have been used by the patient, within two weeks prior to the event were not provided.  The Treatment information was not provided.   This case was linked to MOD-2021-018000 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Myalgia
Clinical narrative: Light headed; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed) and MYALGIA (Achiness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headed) and MYALGIA (Achiness). At the time of the report, DIZZINESS (Light headed) and MYALGIA (Achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and Treatment medications were not provided by reporter.